https://www.selleckchem.com/pr....oducts/Cisplatin.htm
Reported 4Kscore thresholds used to differentiate between patients with and without high-grade prostate cancer (CaP) were variable. Patients with 4Kscore results 7.5% have been proven to be at low risk of carrying high-grade CaP. This study employed a meta-analysis approach in order to assess the diagnostic accuracy of the 4Kscore as a means of detecting high-grade CaP in prostate biopsy samples using cutoff values of 7.5% to 10%. Relevant studies published as of December 2019 were identified via searching PubMed, Embase, and Coch
Like
Comment
Share
